Regen Therapeutics PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Regen Therapeutics PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Regen Therapeutics PLC. The Group's principal activities are developing healthcare products both nutraceutical and ethical pharmaceuticals and conducting pharmacokinetic and pharmacodynamic research. Its operation focuses on the research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex derived from ovine and bovine colostrum. The Group operates solely in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report